MetLife Investment Management’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
19,764
+401
| +2% | +$53.7K | 0.02% | 863 |
|
|
2025
Q1 | $1.3M | Sell |
19,363
-277
| -1% | -$18.6K | 0.01% | 1234 |
|
|
2024
Q4 | $1.22M | Buy |
19,640
+1,116
| +6% | +$69.6K | 0.01% | 1313 |
|
|
2024
Q3 | $2.91M | Hold |
18,524
| – | – | 0.02% | 818 |
|
|
2024
Q2 | $2.79M | Buy |
18,524
+1,976
| +12% | +$298K | 0.02% | 817 |
|
|
2024
Q1 | $1.22M | Hold |
16,548
| – | – | 0.01% | 1187 |
|
|
2023
Q4 | $1.31M | Hold |
16,548
| – | – | 0.01% | 1164 |
|
|
2023
Q3 | $906K | Hold |
16,548
| – | – | 0.01% | 1280 |
|
|
2023
Q2 | $1.39M | Buy |
16,548
+358
| +2% | +$30.1K | 0.01% | 1088 |
|
|
2023
Q1 | $1.23M | Hold |
16,190
| – | – | 0.01% | 1125 |
|
|
2022
Q4 | $999K | Hold |
16,190
| – | – | 0.01% | 1213 |
|
|
2022
Q3 | $676K | Buy |
16,190
+1,967
| +14% | +$82.1K | 0.01% | 1420 |
|
|
2022
Q2 | $447K | Sell |
14,223
-1,338
| -9% | -$42.1K | ﹤0.01% | 1740 |
|
|
2022
Q1 | $419K | Buy |
15,561
+6,307
| +68% | +$170K | ﹤0.01% | 1882 |
|
|
2021
Q4 | $177K | Hold |
9,254
| – | – | ﹤0.01% | 2124 |
|
|
2021
Q3 | $306K | Sell |
9,254
-2,965
| -24% | -$98.1K | ﹤0.01% | 1813 |
|
|
2021
Q2 | $405K | Hold |
12,219
| – | – | ﹤0.01% | 1696 |
|
|
2021
Q1 | $507K | Hold |
12,219
| – | – | ﹤0.01% | 1514 |
|
|
2020
Q4 | $243K | Hold |
12,219
| – | – | ﹤0.01% | 1867 |
|
|
2020
Q3 | $168K | Hold |
12,219
| – | – | ﹤0.01% | 1958 |
|
|
2020
Q2 | $219K | Buy |
12,219
+4,842
| +66% | +$86.8K | ﹤0.01% | 1857 |
|
|
2020
Q1 | $89.1K | Hold |
7,377
| – | – | ﹤0.01% | 2135 |
|
|
2019
Q4 | $140K | Buy |
+7,377
| New | +$140K | ﹤0.01% | 2160 |
|